Trending
- Cevostamab Combo Shows Durable Responses in R/R Multiple Myeloma
- MELT-MM Regimen Yields Responses in Relapsed/Refractory Multiple Myeloma
- Belzutifan Combo Receives FDA Approval in Advanced Clear Cell RCC
- SOHO-02 Trial Will Confirm Sevabertinib’s Frontline NSCLC Benefit
- Synonymous codon usage shapes ERα function through specialized translational programs during breast cancer progression
- FDA Panel Narrowly Backs Multi-Cancer Blood Test Despite Doubts It Works
- Anselamimab’s Kappa Subgroup Signal Could Reshape Anti-Fibril Therapy in AL Amyloidosis
- Free counselling for blood cancer patients
Thursday, September 24